A Doctor Puts the Drug Industry Under a Microscope
129442
Dr. Marcia Angell, a pathologist and former editor of The New England Journal of Medicine, is taking on the American pharmaceutical industry.
371145
As drug makers are increasingly scrutinized for their relationships to researchers, the Cleveland Clinic Foundation's chief academic officer is finding himself under the spotlight.
37904
The drug maker's difficulties are evident, but its productivity may make it worth a second look.
566909
The FDA decides to debate the company's lead drug.
112421
The medical profession has a costly, little-known secret: Many treatments don&#39;t work all that well for many -- even most -- people.
682554
Last December, medical school researchers came to a professional meeting in Puerto Rico with a sense of urgency. Federal drug regulators were reviewing unpublished data from their studies on
657178
When painful medicine is involved, closeness to a patient can make for fuzzy views.
103275
An investigation has been launched to investigate whether drug firms have been fixing the market to squeeze out copycat medicines
130259
SOME of Britainâs most popular medicines are to be reviewed by drug regulators after claims by an American scientist that they pose severe risks to patients and should not be prescribed.
376526
Many doctors prescribe medicine without providing detailed information about it to patients, a new study suggests.
125115
If they want more new drugs, they shouldn't be looking at the pharmaceutical industry.
158632
When Raymond Gilmartin became chairman of the drug maker Merck, it was close to introducing several new medicines. Now, the company is in crisis.
635713
Outside experts who advise the government on drugs and other regulated products often have financial ties to industry, creating the potential for conflicts of interest.
8068
Drug makers are exploring the possibility of tying pharmaceutical prices to performance.
640990
Now might be a great time to load up on cutting-edge drug makers.
425170
Faced with weak development pipelines that are putting a drag on stock prices, drug manufacturers are retooling the decades-old system of clinical trials to make it faster and cheaper.
589260
Consumer Reports' effort to rate drugs offers a lesson to pharmaceutical companies.